{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:49:33Z","timestamp":1792399773887,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.cca.2018.08.038","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T02:00:24Z","timestamp":1535335224000},"page":"249-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["A simple screening method for the diagnosis of chronic myeloid leukemia using the parameters of a complete blood count and differentials"],"prefix":"10.1016","volume":"489","author":[{"given":"Atsushi","family":"Ogasawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1629-6630","authenticated-orcid":false,"given":"Hiromichi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Shirasugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2018.08.038_bb0005","series-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues (Revised 4th Edition), IARC, Lyon","first-page":"30","article-title":"Chronic myeloid leukemia, BCR-ABL1-positive","author":"Vardiman","year":"2017"},{"key":"10.1016\/j.cca.2018.08.038_bb0010","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2018.08.038_bb0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.clml.2013.05.012","article-title":"A critical review of trials of first-line BCR-ABL inhibitor treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase","volume":"13","author":"Jabbour","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.cca.2018.08.038_bb0020","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1200\/JCO.2015.64.8899","article-title":"Final 5-Year Study results of DASISION: the Dasatinib Versus Imatinib Study in Treatment-Na\u00efve Chronic Myeloid Leukemia patients Trial","volume":"34","author":"Cortes","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cca.2018.08.038_bb0025","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/leu.2016.5","article-title":"Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial","volume":"30","author":"Hochhaus","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.cca.2018.08.038_bb0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.beha.2016.10.005","article-title":"Management of CML-blast crisis","volume":"29","author":"Hehlmann","year":"2016","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.cca.2018.08.038_bb0035","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.14694\/EdBook_AM.2015.35.e381","article-title":"Diagnosing and managing advanced chronic myeloid leukemia","author":"Deininger","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book."},{"key":"10.1016\/j.cca.2018.08.038_bb0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1182\/blood-2012-03-380147","article-title":"How I treat CML blast crisis","volume":"120","author":"Hehlmann","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cca.2018.08.038_bb0045","doi-asserted-by":"crossref","unstructured":"D.S. Rosenthal, S.L. Schrier, J.S. Timauer, Evaluation of the peripheral blood smear, Post TW (eds.), UpToDate. Waltham, MA: UpToDate Inc. Available at: http:\/\/www.uptodate.com. Accessed: 23 February 2018.","DOI":"10.1097\/01.COT.0000534134.03023.2f"},{"key":"10.1016\/j.cca.2018.08.038_bb0050","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12185-015-1777-1","article-title":"The criteria to suspect chronic myeloid leukemia using absolute basophil counts in peripheral blood","volume":"101","author":"Masuda","year":"2015","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.cca.2018.08.038_bb0055","doi-asserted-by":"crossref","first-page":"e1001","DOI":"10.1200\/JOP.2016.014449","article-title":"BCR- ABL testing by polymerase chain reaction in patients with neutrophilia: the William Beaumont hospital experience and the case for rational laboratory test requests","volume":"12","author":"Ogunleye","year":"2016","journal-title":"J Oncol Pract."},{"key":"10.1016\/j.cca.2018.08.038_bb0060","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2018.08.038_bb0065","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2","volume":"369","author":"Jain","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2018.08.038_bb0070","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1186\/s40064-016-2829-6","article-title":"Low neutrophil alkaline phosphatase score is a new aspect of calreticulin-mutated myeloproliferative neoplasms","volume":"5","author":"Kondo","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.cca.2018.08.038_bb0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V60.1.113.113","article-title":"Basophil production in myeloproliferative disorders: increases during acute blastic transformation of chronic myeloid leukemia","volume":"60","author":"Aichberger","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.cca.2018.08.038_bb0080","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in \u201cgood-risk\u201d chronic granulocytic leukemia","volume":"63","author":"Sokal","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.cca.2018.08.038_bb0085","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(98)03030-X","article-title":"Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation, Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"352","author":"Gratwohl","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2018.08.038_bb0090","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jnci\/90.11.850","article-title":"A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group","volume":"90","author":"Hasford","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cca.2018.08.038_bb0095","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2005-12-028456","article-title":"The CML-related oncoprotein BCR\/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells","volume":"108","author":"Aichberger","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cca.2018.08.038_bb0100","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1182\/blood.V73.7.1763.1763","article-title":"Interleukin-3 is a differentiation factor for human basophils","volume":"73","author":"Valent","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.cca.2018.08.038_bb0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/bbrc.1993.1396","article-title":"Interleukin 3 promotes histamine synthesis in hematopoietic progenitors by increasing histidine decarboxylase mRNA expression","volume":"192","author":"Dy","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2018.08.038_bb0110","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/13696998.2017.1345750","article-title":"Evaluation of healthcare resource utilization and incremental economic burden of patients with chronic myeloid leukemia after disease progression to blast phase","volume":"20","author":"Jabbour","year":"2017","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.cca.2018.08.038_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbmt.2007.10.010","article-title":"Costs of Allogeneic Hematopoietic Cell Transplantation with High-Dose Regimens","volume":"14","author":"Saito","year":"2008","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.cca.2018.08.038_bb0120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3111\/13696990802354683","article-title":"Cost utility of allogeneic stem cell transplantation with matched unrelated donor versus treatment with imatinib for adult patients with newly diagnosed chronic myeloid leukaemia","volume":"11","author":"Breitscheidel","year":"2008","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.cca.2018.08.038_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1592\/phco.25.3.325.61593","article-title":"Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach","volume":"25","author":"Skrepnek","year":"2005","journal-title":"Pharmacotherapy"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118304534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118304534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:47:27Z","timestamp":1757861247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898118304534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":25,"alternative-id":["S0009898118304534"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2018.08.038","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A simple screening method for the diagnosis of chronic myeloid leukemia using the parameters of a complete blood count and differentials","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2018.08.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}